These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 11567908)
1. [Oxaliplatin: a first DACH-platinum in oncology]. Laadem A; Cvitkovic E Bull Cancer; 2001 Aug; 88 Spec No():S9-13. PubMed ID: 11567908 [TBL] [Abstract][Full Text] [Related]
2. [Oxaliplatin: the first DACH platinum in clinical practice]. Soulié P; Raymond E; Brienza S; Cvitkovic E Bull Cancer; 1997 Jun; 84(6):665-73. PubMed ID: 9295871 [TBL] [Abstract][Full Text] [Related]
3. Review of oxaliplatin: an active platinum agent in colorectal cancer. Cassidy J Int J Clin Pract; 2000; 54(6):399-402. PubMed ID: 11092115 [TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin: a review of preclinical and clinical studies. Raymond E; Chaney SG; Taamma A; Cvitkovic E Ann Oncol; 1998 Oct; 9(10):1053-71. PubMed ID: 9834817 [TBL] [Abstract][Full Text] [Related]
5. Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies. Culy CR; Clemett D; Wiseman LR Drugs; 2000 Oct; 60(4):895-924. PubMed ID: 11085200 [TBL] [Abstract][Full Text] [Related]
6. [Oxaliplatin in combination with 5-fluoro-uracil and folinic acid as treatment of metastatic colorectal cancer]. André T; Louvet C; Maindrault-Goebel F; Gramont AD Bull Cancer; 2001 Aug; 88 Spec No():S20-5. PubMed ID: 11567910 [TBL] [Abstract][Full Text] [Related]
7. Oxaliplatin (L-OHP): a new reality in colorectal cancer. Bleiberg H Br J Cancer; 1998 Jun; 77 Suppl 4(Suppl 4):1-3. PubMed ID: 9647611 [TBL] [Abstract][Full Text] [Related]
8. Platinum compounds in the treatment of advanced breast cancer. Martín M Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413 [TBL] [Abstract][Full Text] [Related]
9. Current status of oxaliplatin in colorectal cancer. O'Dwyer PJ; Johnson SW Semin Oncol; 2003 Jun; 30(3 Suppl 6):78-87. PubMed ID: 12802798 [TBL] [Abstract][Full Text] [Related]
10. Doublet chemotherapy vs. single-agent therapy with 5FU in elderly patients with metastatic colorectal cancer. a meta-analysis. Landre T; Uzzan B; Nicolas P; Aparicio T; Zelek L; Mary F; Taleb C; Des Guetz G Int J Colorectal Dis; 2015 Oct; 30(10):1305-10. PubMed ID: 26099322 [TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin: mechanism of action and antineoplastic activity. Raymond E; Faivre S; Woynarowski JM; Chaney SG Semin Oncol; 1998 Apr; 25(2 Suppl 5):4-12. PubMed ID: 9609103 [TBL] [Abstract][Full Text] [Related]
12. [Oxaliplatin]. Furue H Gan To Kagaku Ryoho; 2005 Aug; 32(8):1195-202. PubMed ID: 16121929 [TBL] [Abstract][Full Text] [Related]
13. Oxaliplatin: a new therapeutic option in colorectal cancer. Cvitkovic E; Bekradda M Semin Oncol; 1999 Dec; 26(6):647-62. PubMed ID: 10606258 [TBL] [Abstract][Full Text] [Related]
14. Ongoing and unsaid on oxaliplatin: the hope. Cvitkovic E Br J Cancer; 1998 Jun; 77 Suppl 4(Suppl 4):8-11. PubMed ID: 9647613 [TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin: a novel platinum analog with activity in colorectal cancer. Berg D Oncol Nurs Forum; 2003; 30(6):957-66. PubMed ID: 14603353 [TBL] [Abstract][Full Text] [Related]